Order Article Reprints

Zhai L, Balachandran A, Larkin R, Seneviratne JA, Chung SA, Lalwani A, Tsubota S, Beck D, Kadomatsu K, Beckers A, et al. Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma. International Journal of Molecular Sciences. 2023; 24(21):15571. https://doi.org/10.3390/ijms242115571

Zhai, Lei, Anushree Balachandran, Rebecca Larkin, Janith A. Seneviratne, Sylvia A. Chung, Amit Lalwani, Shoma Tsubota, Dominik Beck, Kenji Kadomatsu, Anneleen Beckers, and et al. 2023. "Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma" International Journal of Molecular Sciences 24, no. 21: 15571. https://doi.org/10.3390/ijms242115571

Zhai, L., Balachandran, A., Larkin, R., Seneviratne, J. A., Chung, S. A., Lalwani, A., Tsubota, S., Beck, D., Kadomatsu, K., Beckers, A., Durink, K., De Preter, K., Speleman, F., Haber, M., Norris, M. D., Swarbrick, A., Cheung, B. B., Marshall, G. M., & Carter, D. R. (2023). Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma. International Journal of Molecular Sciences, 24(21), 15571. https://doi.org/10.3390/ijms242115571